Výsledky vyhledávání - Czuczman, Myron

Ofatumumab Exhibits Enhanced In Vitro and In Vivo Activity Compared to Rituximab in Preclinical Models of Mantle Cell Lymphoma Autor Barth, Matthew J., Mavis, Cory, Czuczman, Myron S., Hernandez-Ilizaliturri, Francisco J.

Získat plný text Získat plný text Získat plný text

Regulation of CD20 in rituximab-resistant cell lines (RRCL) and B-cell non-Hodgkin lymphoma (B-NHL) Autor Tsai, Ping-Chiao, Hernandez-Ilizaliturri, Francisco J., Bangia, Naveen, Olejniczak, Scott, Czuczman, Myron S.

Získat plný text Získat plný text Získat plný text

Mitotic catastrophe and cell cycle arrest are alternative cell death pathways executed by bortezomib in rituximab resistant B-cell lymphoma cells Autor Gu, Juan J., Kaufman, Gregory P., Mavis, Cory, Czuczman, Myron S, Hernand ez-Ilizaliturri, Francisco J.

Získat plný text Získat plný text Získat plný text

The novel proteasome inhibitor carfilzomib (CFZ) induces cell cycle arrest, apoptosis and potentiates the anti-tumour activity of chemotherapy in rituximab-resistant lymphoma Autor Gu, Juan J., Hernandez-Ilizaliturri, Francisco J., Kaufman, Gregory P., Czuczman, Natalie M., Mavis, Cory, Skitzki, Joseph J., Czuczman, Myron S.

Získat plný text Získat plný text Získat plný text

Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody Autor Goldenberg, David M., Rossi, Edmund A., Stein, Rhona, Cardillo, Thomas M., Czuczman, Myron S., Hernandez-Ilizaliturri, Francisco J., Hansen, Hans J., Chang, Chien-Hsing

Získat plný text Získat plný text Získat plný text

MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-se... Autor Gu, Juan J., Hernandez-Ilizaliturri, Francisco J., Mavis, Cory, Czuczman, Natalie M., Deeb, George, Gibbs, John, Skitzki, Joseph J., Patil, Ritesh, Czuczman, Myron S.

Získat plný text Získat plný text Získat plný text

Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents Autor Frys, Sarah, Simons, Zachary, Hu, Qiang, Barth, Matthew J., Gu, Juan J., Mavis, Cory, Skitzki, Joseph, Song, Liu, Czuczman, Myron S., Hernandez-Ilizaliturri, Francisco J.

Získat plný text Získat plný text Získat plný text

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma Autor Dunleavy, Kieron, Pittaluga, Stefania, Czuczman, Myron S., Dave, Sandeep S., Wright, George, Grant, Nicole, Shovlin, Margaret, Jaffe, Elaine S., Janik, John E., Staudt, Louis M., Wilson, Wyndham H.

Získat plný text Získat plný text Získat plný text

Distinct molecular mechanisms responsible for bortezomib-induced death of therapy-resistant versus -sensitive B-NHL cells Autor Olejniczak, Scott H., Blickwedehl, Jennifer, Belicha-Villanueva, Alan, Bangia, Naveen, Riaz, Wasif, Mavis, Cory, Clements, James L., Gibbs, John, Hernandez-Ilizaliturri, Francisco J., Czuczman, Myron S.

Získat plný text Získat plný text Získat plný text

Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development Autor Gu, Juan J., Singh, Anil, Xue, Kai, Mavis, Cory, Barth, Matthew, Yanamadala, Vivek, Lenz, Peter, Grau, Michael, Lenz, Georg, Czuczman, Myron S., Hernandez-Ilizaliturri, Francisco J.

Získat plný text Získat plný text Získat plný text

Comparison of Referring and Final Pathology for Patients With Non-Hodgkin's Lymphoma in the National Comprehensive Cancer Network Autor LaCasce, Ann S., Kho, Michelle E., Friedberg, Jonathan W., Niland, Joyce C., Abel, Gregory A., Rodriguez, Maria Alma, Czuczman, Myron S., Millenson, Michael M., Zelenetz, Andrew D., Weeks, Jane C.

Získat plný text Získat plný text Získat plný text

CALGB 150905 (Alliance): Rituximab broadens the anti-lymphoma response by activating unlicensed NK cells Autor Du, Juan, Lopez-Verges, Sandra, Pitcher, Brandelyn N., Johnson, Jeffrey, Jung, Sin-Ho, Zhou, Lili, Hsu, Katharine, Czuczman, Myron S., Cheson, Bruce, Kaplan, Lawrence, Lanier, Lewis L., Venstrom, Jeffrey M.

Získat plný text Získat plný text Získat plný text

Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo Autor Czuczman, Natalie M., Barth, Matthew J., Gu, Juan, Neppalli, Vishala, Mavis, Cory, Frys, Sarah E., Hu, Qiang, Liu, Song, Klener, Pavel, Vockova, Petra, Czuczman, Myron S., Hernandez-Ilizaliturri, Francisco J.

Získat plný text Získat plný text Získat plný text

Bendamustine Is Effective Therapy in Patients With Rituximab-Refractory, Indolent B-cell Non-Hodgkin Lymphoma: Results From a Multicenter Study Autor Kahl, Brad S., Bartlett, Nancy L., Leonard, John P., Chen, Ling, Ganjoo, Kristen, Williams, Michael E., Czuczman, Myron S., Robinson, K. Sue, Joyce, Robin, van der Jagt, Richard H., Cheson, Bruce D.

Získat plný text Získat plný text Získat plný text

Cardiotoxicity as indicated by LVEF and troponin T sensitivity following two anthracycline-based regimens in lymphoma: Results from a randomized prospective clinical trial Autor Xue, Kai, Gu, Juan J., Zhang, Qunling, Liu, Xiaojian, Wang, Jiachen, Li, Xiao-qiu, Luo, Jianfeng, Hernandez, Francisco J., Fernandez, Stanley F., Czuczman, Myron S., Cao, Junning, Hong, Xiaonan, Guo, Ye

Získat plný text Získat plný text Získat plný text

The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials Autor Lansigan, Frederick, Barak, Ian, Pitcher, Brandelyn, Jung, Sin‐Ho, Cheson, Bruce D., Czuczman, Myron, Martin, Peter, Hsi, Eric, Schöder, Heiko, Smith, Scott, Bartlett, Nancy L., Leonard, John P., Blum, Kristie A.

Získat plný text Získat plný text Získat plný text

Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and... Autor Chanan-Khan, Asher A., Chitta, Kasyapa, Ersing, Noreen, Paulus, Aneel, Masood, Aisha, Sher, Taimur, Swaika, Abhisek, Wallace, Paul K., Mashtare, Terry L., Wilding, Greg, Lee, Kelvin, Czuczman, Myron S., Borrello, Ivan, Bangia, Naveen

Získat plný text Získat plný text Získat plný text

Population Pharmacokinetics of an Anti-PD-L1 Antibody, Durvalumab in Patients with Hematologic Malignancies Autor Ogasawara, Ken, Newhall, Kathryn, Maxwell, Stephen E., Dell’Aringa, Justine, Komashko, Vitalina, Kilavuz, Nurgul, Delarue, Richard, Czuczman, Myron, Sternas, Lars, Rose, Shelonitda, Beach, C. L., Novick, Steven, Zhou, Simon, Palmisano, Maria, Li, Yan

Získat plný text Získat plný text Získat plný text

A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype Autor Wilson, Wyndham H., Jung, Sin-Ho, Porcu, Pierluigi, Hurd, David, Johnson, Jeffrey, Martin, S. Eric, Czuczman, Myron, Lai, Raymond, Said, Jonathan, Chadburn, Amy, Jones, Dan, Dunleavy, Kieron, Canellos, George, Zelenetz, Andrew D., Cheson, Bruce D., Hsi, Eric D.

Získat plný text Získat plný text Získat plný text

Radiation for Diffuse Large B Cell Lymphoma in the Rituximab Era: Analysis of the National Comprehensive Cancer Network Lymphoma Outcomes Project Autor Dabaja, Bouthaina, Vanderplas, Ann M., Crosby-Thompson, Allison L., Abel, Gregory A., Czuczman, Myron S., Friedberg, Jonathan W., Gordon, Leo. I, Kaminski, Mark, Niland, Joyce, Millenson, Michael, Nademanee, Auayporn P., Zelenetz, Andrew, LaCasce, Ann S., Rodriguez, Maria Alma

Získat plný text Získat plný text Získat plný text